Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 830 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pain, Cancer Clear all

Conditions: Cancer
Interventions: Camp Discovery; Other
Lead sponsor: Temple University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Postoperative Pain, Acute, Skin Cancer
Interventions: Meloxicam 7.5 mg, Meloxicam 15 mg, Acetaminophen 500mg; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 110 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Opioid Use, Auriculotherapy, Pain, Abdominal, Cancer Pain, Liver Transplant
Interventions: NSS-2 BRIDGE, Sham NSS-2 BRIDGE; Device
Lead sponsor: Jacques E. Chelly; Other
Eligibility: 18 Years and older
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Pittsburgh, Pennsylvania

Conditions: Oropharyngeal Cancer, Squamous Cell Carcinoma to the Head and Neck
Interventions: Lyrica 300 mg, Placebo; Drug
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pain, Neoplasm Metastasis, Bone Metastasis of Diverse Origins
Interventions: Cryoablation; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 7
States / cities: Los Angeles, California • Atlanta, Georgia • Boston, Massachusetts + 4 more

Conditions: Schwannomatosis, Schwannomas, Pain, Chronic
Interventions: Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo, Erenumab-Aooe Matching Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer-related Problem/Condition, Head and Neck Cancer, Pain
Interventions: glutamine, radiation therapy, l-glutamine placebo; Dietary Supplement · Radiation · Drug
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years to 90 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 106
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 68 more

Conditions: Metastases
Interventions: Stereotactic radiotherapy; Radiation
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Illness, Hematologic Malignancy, Bone Marrow Transplant Infection, Oncology, Sickle Cell Disease
Interventions: Guided Imagery, Virtual Reality; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 8 Years to 25 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Milwaukee, Wisconsin • Wauwatosa, Wisconsin

Conditions: Head and Neck Cancer (H&N)
Interventions: Standard Closure (Control), Avive+ Intervention; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Cancer, Cancer Pain
Interventions: Guided imagery, Virtual reality; Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Bladder Carcinoma
Interventions: Gabapentin, Placebo, Questionnaire Administration; Drug · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 75 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Chronic Neuropathic Pain
Interventions: Surgical Management of Neuroma; Procedure
Lead sponsor: Axogen Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Tampa, Florida • Indianapolis, Indiana • Salt Lake City, Utah + 1 more

Conditions: Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Interventions: Music Therapy, No music therapy; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cancer of Head and Neck, Pain, Face, Pain, Neck
Interventions: ExAblate Neuro; Device
Lead sponsor: Jeff Elias, MD; Other
Eligibility: 18 Years to 75 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Neoplasms, Bone Metastases
Interventions: Anti-NGF AB; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 6
States / cities: La Jolla, California • Shreveport, Louisiana • Salt Lake City, Utah

Conditions: Pain, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: lidocaine, placebo; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years to 120 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 159
States / cities: Scottsdale, Arizona • Washington D.C., District of Columbia • Jacksonville, Florida + 95 more

Conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neurotoxicity Syndrome, Pain, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
Interventions: Cytology Specimen Collection Procedure, Pharmacological Study; Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Up to 15 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Prostate Cancer
Interventions: 16 French urinary catheter, 20 French urinary catheter; Device
Lead sponsor: Benaroya Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Head and Neck Cancer, Pain, Lung Cancer, Esophageal Cancer
Interventions: Telephone-Based Intervention, Questionnaire Administration; Behavioral · Other
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Arthritis, Pain, Cognitive Impairment
Interventions: long acting oxycodone, extra strength acetaminophen; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 65 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dysmenorrhea Primary, Dysmenorrhea, Menstrual Discomfort, Menstrual Problem, Menstrual Cycle Abnormal, Menstrual Pain, Period Pain, Period Problem, PMS, Premenstrual Syndrome, PCOS, PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, PCOS (Polycystic Ovary Syndrome) of Left Ovary, PCOS (Polycystic Ovary Syndrome) of Right Ovary, Polycystic Ovary Syndrome, Premenstrual Dysphoric Disorder, Cramps, Ovarian Cysts
Interventions: Cramp Bites by Aunt Flo's Kitchen; Dietary Supplement
Lead sponsor: Cornell University; Other
Eligibility: 18 Years to 25 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Ithaca, New York

Conditions: Head and Neck Cancer
Interventions: Electronic Patient Visit Assessment (ePVA); Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer, Cancers, Pain
Interventions: Oral cannabis low THC, Placebo Comparator, Oral cannabis high THC, Oral cannabis THC/CBD; Drug
Lead sponsor: Shanna Babalonis, PhD; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Lexington, Kentucky

Search by objective public record fields.

Implementation and Evaluation of an Activity Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer

Meloxicam in Mohs Micrographic Surgery

Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.

Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain

Distracting Through Procedural Pain and Distress

Evaluating Avive+ Soft Tissue Matrix for Prevention of Superficial Radial Nerve Morbidity Following Radial Forearm Free Flap Harvest

Virtual Reality for Cancer Pain Management

Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy

Surgical Treatment of Chronic Neuropathic Pain

Music Therapy on Nausea and Pain for Autologous Stem Cell

Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain

Open Label Extension In Cancer Patients

Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery

Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy

Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy

Non-cancer Pain and Cognitive Impairment: A Disabling Relationship

Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25

A Feasibility Study to Evaluate The Effect of the Electronic Patient Visit Assessment On Pain and Quality of Life for Patients With Head and Neck Cancer (HNC)

Impact of Daily Oral Cannabis Doses in Patients With Cancer